
John M. Hoffmann
Examiner (ID: 5190, Phone: (571)272-1191 , Office: P/1741 )
| Most Active Art Unit | 1731 |
| Art Unit(s) | 1712, 1731, 1741, 1791, 1304, 1303 |
| Total Applications | 1565 |
| Issued Applications | 722 |
| Pending Applications | 142 |
| Abandoned Applications | 703 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17342220
[patent_doc_number] => 20220008551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => POLYPEPTIDE CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 17/293134
[patent_app_country] => US
[patent_app_date] => 2019-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -65
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17293134
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/293134 | POLYPEPTIDE CONJUGATES | Nov 17, 2019 | Abandoned |
Array
(
[id] => 16072357
[patent_doc_number] => 20200190165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => COMPOUND HAVING AFFINITY SUBSTANCE TO SOLUBLE PROTEIN, CLEAVABLE PORTION AND REACTIVE GROUP, OR SALT THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/663791
[patent_app_country] => US
[patent_app_date] => 2019-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 102572
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16663791
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/663791 | Compound having affinity substance to soluble protein, cleavable portion and reactive group, or salt thereof | Oct 24, 2019 | Issued |
Array
(
[id] => 16238310
[patent_doc_number] => 20200255544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => METHODS FOR TREATING HIGH CARDIOVASCULAR RISK PATIENTS WITH HYPERCHOLESTEROLEMIA
[patent_app_type] => utility
[patent_app_number] => 16/662313
[patent_app_country] => US
[patent_app_date] => 2019-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44750
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16662313
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/662313 | METHODS FOR TREATING HIGH CARDIOVASCULAR RISK PATIENTS WITH HYPERCHOLESTEROLEMIA | Oct 23, 2019 | Abandoned |
Array
(
[id] => 19060163
[patent_doc_number] => 11939372
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => Binding agents
[patent_app_type] => utility
[patent_app_number] => 16/661669
[patent_app_country] => US
[patent_app_date] => 2019-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 46501
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16661669
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/661669 | Binding agents | Oct 22, 2019 | Issued |
Array
(
[id] => 17221832
[patent_doc_number] => 11174323
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-16
[patent_title] => Method of treating renal cancer using carbonic anhydrase IX (G250) antibodies
[patent_app_type] => utility
[patent_app_number] => 16/658867
[patent_app_country] => US
[patent_app_date] => 2019-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 26407
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16658867
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/658867 | Method of treating renal cancer using carbonic anhydrase IX (G250) antibodies | Oct 20, 2019 | Issued |
Array
(
[id] => 19473880
[patent_doc_number] => 12103956
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-01
[patent_title] => Suicide module compositions and methods
[patent_app_type] => utility
[patent_app_number] => 17/270827
[patent_app_country] => US
[patent_app_date] => 2019-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 18734
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17270827
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/270827 | Suicide module compositions and methods | Sep 29, 2019 | Issued |
Array
(
[id] => 16176949
[patent_doc_number] => 20200223917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => ANTIBODY MOLECULES TO TIM-3 AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/588063
[patent_app_country] => US
[patent_app_date] => 2019-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16588063
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/588063 | Method of detecting TIM-3 using antibody molecules to TIM-3 | Sep 29, 2019 | Issued |
Array
(
[id] => 15993523
[patent_doc_number] => 20200172632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF GLUTAMINYL-TRNA SYNTHETASES
[patent_app_type] => utility
[patent_app_number] => 16/585805
[patent_app_country] => US
[patent_app_date] => 2019-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16585805
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/585805 | INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF GLUTAMINYL-TRNA SYNTHETASES | Sep 26, 2019 | Abandoned |
Array
(
[id] => 15678393
[patent_doc_number] => 20200093860
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => ANTIGEN BINDING RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 16/576546
[patent_app_country] => US
[patent_app_date] => 2019-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58852
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16576546
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/576546 | Antigen binding receptors specific for mutated Fc domains | Sep 18, 2019 | Issued |
Array
(
[id] => 15866335
[patent_doc_number] => 20200140571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF METHIONYL-TRNA SYNTHETASES
[patent_app_type] => utility
[patent_app_number] => 16/570591
[patent_app_country] => US
[patent_app_date] => 2019-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 80264
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16570591
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/570591 | INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF METHIONYL-TRNA SYNTHETASES | Sep 12, 2019 | Abandoned |
Array
(
[id] => 17875571
[patent_doc_number] => 11447572
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => Anti-ceramide antibodies
[patent_app_type] => utility
[patent_app_number] => 16/568152
[patent_app_country] => US
[patent_app_date] => 2019-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 17
[patent_no_of_words] => 11832
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16568152
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/568152 | Anti-ceramide antibodies | Sep 10, 2019 | Issued |
Array
(
[id] => 15296029
[patent_doc_number] => 20190391150
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => COMPOSITIONS AND METHODS FOR CAPTURING EXOSOMES
[patent_app_type] => utility
[patent_app_number] => 16/566273
[patent_app_country] => US
[patent_app_date] => 2019-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16566273
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/566273 | COMPOSITIONS AND METHODS FOR CAPTURING EXOSOMES | Sep 9, 2019 | Abandoned |
Array
(
[id] => 18434464
[patent_doc_number] => 20230181758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => EXTRACELLULAR VESICLES TARGETING DENDRITIC CELLS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/271176
[patent_app_country] => US
[patent_app_date] => 2019-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44984
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17271176
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/271176 | EXTRACELLULAR VESICLES TARGETING DENDRITIC CELLS AND USES THEREOF | Aug 22, 2019 | Abandoned |
Array
(
[id] => 15915421
[patent_doc_number] => 10654940
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => Method for treating joint damage
[patent_app_type] => utility
[patent_app_number] => 16/526727
[patent_app_country] => US
[patent_app_date] => 2019-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 49
[patent_no_of_words] => 51468
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16526727
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/526727 | Method for treating joint damage | Jul 29, 2019 | Issued |
| 16/475876 | Biomarkers For Detecting Human Glycogen Phosphorylase Isoenzyme BB | Jul 2, 2019 | Abandoned |
Array
(
[id] => 15363675
[patent_doc_number] => 20200017602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-16
[patent_title] => PLASMA KALLIKREIN BINDING PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/445304
[patent_app_country] => US
[patent_app_date] => 2019-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70762
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16445304
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/445304 | Nucleic acids encoding plasma kallikrein binding proteins | Jun 18, 2019 | Issued |
Array
(
[id] => 16779367
[patent_doc_number] => 20210116445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-22
[patent_title] => METHOD FOR SEPARATING ANTIBODY, AND METHOD FOR TESTING ON DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/253824
[patent_app_country] => US
[patent_app_date] => 2019-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22820
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17253824
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/253824 | Method for separating antibody, and method for testing on disease | Jun 17, 2019 | Issued |
Array
(
[id] => 15408085
[patent_doc_number] => 20200024364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => DOSING REGIMENS FOR USE WITH PCSK9 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 16/415837
[patent_app_country] => US
[patent_app_date] => 2019-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16415837
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/415837 | DOSING REGIMENS FOR USE WITH PCSK9 INHIBITORS | May 16, 2019 | Abandoned |
Array
(
[id] => 18013338
[patent_doc_number] => 11505620
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-22
[patent_title] => Methods of detecting plasma kallikrein
[patent_app_type] => utility
[patent_app_number] => 16/411242
[patent_app_country] => US
[patent_app_date] => 2019-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 67842
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 1572
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16411242
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/411242 | Methods of detecting plasma kallikrein | May 13, 2019 | Issued |
Array
(
[id] => 16500006
[patent_doc_number] => 10865382
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-15
[patent_title] => Reducing immune tolerance induced by PD-L1
[patent_app_type] => utility
[patent_app_number] => 16/404349
[patent_app_country] => US
[patent_app_date] => 2019-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13859
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16404349
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/404349 | Reducing immune tolerance induced by PD-L1 | May 5, 2019 | Issued |